AFI Japan deals with development, manufacture and sale of devices that supports the industrialization of regenerative medicine.
AFI Technology manufactures and sells products that use this technology, and responds to a wide range of requests, such as rapid microbiological testing.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Feb 13, 2018 | Series B | ¥430M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Chuo Shinkin Venture Capital | — | Series B |